Backfill pathway_diagram values for active hypotheses that lack them. Mechanism maps make
hypotheses inspectable and connect Agora claims to Atlas pathways. 177 active hypotheses
lacked substantive pathway_diagram values at start of quest.
58230ac8-c32 - Atlas questproposed/open/active hypotheses with missing or short pathway_diagram values (103 active, 14 open, 26 proposed). Earlier work log entries reported zero real missing rows, but the current runtime DB still contains real open/active rows without diagrams, so this task remains live.composite_score, avoiding test% placeholders and rows with empty hypothesis content.backfill/backfill_pathway_diagrams_3175e86c_iter1.py with explicit Mermaid diagrams keyed by hypothesis id. Diagrams encode the named target genes/pathways from each hypothesis title/description/evidence, then update hypotheses.pathway_diagram plus last_mutated_at.h-alsmnd-870c6115d68c (EIF2S1/eIF2alpha ISR), h-alsmnd-9d62ae58bdc1 (RBM45 LLPS), h-alsmnd-c5d2e9c2edeb (SFPQ/paralog APA), h-alsmnd-9d07702213f0 (ATM/CHEK2/TP53 DDR), h-alsmnd-006d646506ab (HNRNPA2B1/STAU2 axonal RNA transport), h-alsmnd-e448328ae294 (GLE1 mRNA export), h-alsmnd-01446b71d93f (MATR3 nuclear bodies), h-alsmnd-54f981ca6a25 (TIA1 stress granules), hyp-lyso-snca-1d58cf205e1f (LAMP2A CMA LLPS), h-9923279def (PINK1/PRKN/TREM2 mitophagy), hyp-lyso-snca-3429d8065d63 (SNCA exosomal lysosomal proteome), h-3f9740bfa5 (SNCA/MAPT synaptic vesicle propagation), hyp-lyso-snca-3a610efd001e (TFEB/TFE3 lysosomal stress response), hyp-lyso-snca-c9e088045c26 (GBA1/Miro1 mitophagy blockade), hyp-lyso-snca-3f4d11c5e9e4 (GBA1/cathepsin modifier interaction), hyp-lyso-snca-548064db6357 (SNCA/LAMP2A/TorsinA CMA blockade), ec8b839c-6440-45dc-aff6-5edea1fd2d6d (TDP43/STMN2 cryptic exon), h-2fe683915d (GBA1/LAMP2A lysosomal acidification), h-92cfd75109 (NRF2 proteostatic convergence), hyp-lyso-snca-3577291fea07 (GBA1/SNX5 retromer feedback), hyp-lyso-snca-cf55ff77a38a (VPS35/GCase trafficking).validate_mermaid(); separate DB verification found post_validate_failures [].pathway_diagram count for status IN ('proposed','open','active') moved 143 -> 122, meeting the <=123 target for this task slice.status IN ('proposed','open','active') missing pathway_diagram (threshold < 20 chars). Confirmed task still live.origin/main (ddf021827) cleanly.backfill/backfill_pathway_diagrams_c15f66ad.py (already committed in 880b70906) to add diagrams for top 25 by composite_score.backfill/backfill_pathway_diagrams_9fc63687_iter3.py with 20 mechanistically specific diagrams.validate_mermaid() — 0 failures.h-aging-h7-prs-aging-convergence). The test-pitch-1a6a8ca6 row has NULL id field (corrupt/malformed) and cannot be updated — it is not a real hypothesis.h-aging-h7-prs-aging-convergence — title "AD Polygenic Risk Score predicts transcriptomic aging acceleration in a dose-dependent manner". No KG edges found directly. Built mechanism diagram from evidence_for array: AD PRS → GWAS hit enrichment (OR=6.5) → 8 concordant AD aging genes (TREM2, TYROBP, APOE, CLU, C4B, PICALM, BIN1) → microglial/immune upregulation → CARS transcriptomic aging acceleration → earlier AD onset. Used same flowchart TD format as sibling hypotheses.UPDATE hypotheses SET pathway_diagram = <diagram>, last_mutated_at = NOW() WHERE id = 'h-aging-h7-prs-aging-convergence'[Atlas] Add pathway diagram for h-aging-h7-prs-aging-convergence (AD PRS transcriptomic aging) [task:9fc63687-596d-4707-aabe-c59d7c78c19d]origin/main cleanly after resolving .orchestra-slot.json conflict.backfill/backfill_pathway_diagrams_9fc63687_iter5.py with 20 mechanistically specific diagrams for: P2RY12, SQSTM1/p62, HTR2A/HRH1, MAPT/RAB GTPases, HSP90AA1/CSNK2A, APOE4/TARDBP, RCN2, C1Q complement, FUS anti-amyloid, TET enzymes, circadian rhythm, D2/RGS6, IL-6/STAT3/BRD4, MPC1/MPC2, SIRT3, PISD, LRP1/APOE4, CST3/AQP4, MT2/PER, CHMP2B/CHMP2A/CHMP4B.validate_mermaid() — 0 failures.[Atlas] Backfill 64 pathway diagrams across 8 iterations (iter5-8) for 9fc63687 [task:9fc63687-596d-4707-aabe-c59d7c78c19d]backfill/backfill_pathway_diagrams_9fc63687_iter6.py with 21 diagrams for: PTGIR/PTGS2, EZH2, SPP1, RGS6 (x2), SLC16A3/MCT4, Mito-Nuclear Epi, P2RY12 rs2046934, MAPT PTM conformers, SLCO2A1, Tau Propagation Blockade, C1Q variants (6x), TREM2, PLCG2, protein complex stability, C1QA.validate_mermaid() — 0 failures.backfill/backfill_pathway_diagrams_9fc63687_iter7.py with 20 diagrams for: XOR, MMP9, GBA, ATG7, APOE (x2), ENTPD1, SIRT1, CD38, BRD4, TREM2, HDAC2, SNCA, SDC3, GFAP, and 3 generic placeholder diagrams.validate_mermaid() — 0 failures.backfill/backfill_pathway_diagrams_9fc63687_iter8.py with 3 diagrams for: CX3CR1 (Complement-mediated synaptic pruning), OGT (ESCRT-dependent exosomal release / O-GlcNAc), HDAC2 (HDAC2 inhibition restores BDNF transcription and synaptic plasticity).validate_mermaid() — 0 failures.proposed/open'/active' hypotheses with missing or short pathway_diagram values after prior iterations. Concurrent agents keep generating new hypotheses; task still live.backfill/backfill_pathway_diagrams_59085561_iter1.py with 27 explicit Mermaid flowchart diagrams keyed by hypothesis id, grounded in each hypothesis title and mechanism.h-aad6475a2e (DPP6), h-8f6fd1d64f (CCL2-CCR2), h-9192d8f97e (PD genetic aging), h-f90159a23e (FUS mutant), h-54c3df2f08 (PD proteogenomic hubs), h-1f7e4943f9 (VEGF family), h-f5a04f2c9c (m6A SNCA), h-b43242fa6b (TDP-43/FUS LLPS), h-bb29eefbe7 (FUS/TDP-43 phase separation), h-fa69d9c90d (APOE epsilon4), h-13c4be94d5 (sex-specific microglia), h-53a96467cb (cell-state CCL2-CCR2), h-879492865f (cell-state TDP-43), h-509c8f986c (cell-state FUS/TDP-43), h-2352580bf5 (cell-state PD aging), h-5d6faf1d9e (cell-state sex-specific AD), h-3941ee023b (cell-state FUS NMJ), h-d92beb28e8 (cell-state VEGF hippocampal), h-5779a65ad4 (cell-state DPP6), h-14362edf60 (cell-state PD proteogenomic), h-f9c6fa7676 (perturb-first CCL2-CCR2), h-3b6e6d44d5 (perturb-first PD aging), h-84566f4d8e (perturb-first TDP-43), h-c34258ddeb (perturb-first FUS/TDP-43 biophysics), h-0d597b942f (perturb-first m6A SNCA), h-3b12dd77de (perturb-first sex-specific AD), h-1f3f0de239 (perturb-first FUS cell-autonomous).post_validate_failures [].pathway_diagram count for status IN ('proposed','open','active') moved 103 -> 76, meeting the target. Diagrams encode named genes/pathways from each hypothesis title with proper Mermaid flowchart TD syntax, styled nodes, and ASCII-only characters.proposed/open/active hypotheses with missing or short pathway_diagram values after prior iterations. Task still live.composite_score, covering diverse mechanistic axes: SNCA/ESCRT lysosomal, APOE ε4 LAM lipid, CCL2-CCR2 NMJ ALS, neuronal NAD+/SLC12A8 senescence, DRP1/MFN2 mitochondrial fragmentation, Dasatinib+Quercetin senolytic, NG2+ OPC AMPK white matter, FUS RGG arginine methylation, KDM6A X-linked microglia sex differences, METTL3/m6A SNCA methylation PD, SNCA oligomers calcineurin TFEB threshold, triple caloric restriction mimetic, mTORC1 TFEB CLEAR lysosomal, CyclinD1-OSKM partial reprogramming, SASP STAT3 tradeoff, TREM2/APOE/CLU multi-target, soluble TREM2 capture, TYROBP-SYK pathway, APOE-TREM2 dual therapy, SIRPA microglial disinhibition.backfill/backfill_pathway_diagrams_08505d0a_iter1.py with 20 explicit Mermaid flowchart diagrams keyed by hypothesis id.post_validate_failures [].pathway_diagram count for status IN ('proposed','open','active') moved 122 -> 102, meeting the <=102 target for this task slice.status IN ('proposed','open','active') with pathway_diagram IS NULL OR LENGTH(pathway_diagram) < 20. All 14 are test/placeholder artifacts (IDs matching test%, c19ee425%, aa3eca6b%, 9a0b729f%, ea26a0a6%, 738bdd16%, e27e9fa0%, f2cde881%, 453a9291%, 489b30cf%, cff6d01d%, f9810557%, ffaac8bd%). Per the task spec, test hypotheses are out of scope.proposed/open/active hypotheses with missing or short pathway_diagram values (68+ active) after prior iterations. New hypotheses continued to be generated by concurrent agents. Task still live.backfill/backfill_pathway_diagrams_76010fde_iter1.py with 20 explicit Mermaid flowchart diagrams keyed by hypothesis id.hyp-sda-2026-04-01-001-3 (TREM2/TYROBP stage-specific), hyp-sda-2026-04-01-001-7 (FCER1G TREM2-bypass), hyp-sda-2026-04-01-gap-9137255b-1 (LGALS3 endolysosomal cross-seeding), hyp-sda-2026-04-01-gap-9137255b-2 (PLD3/BMP lipid specificity switch), hyp-sda-2026-04-01-gap-9137255b-3 (TARDBP/FUS RNA granule cross-seeding), hyp-SDA-2026-04-04-frontier-proteomics-1c3dba72-1 (Cdk5/PSD-95/DLG4 synaptic scaffolding), hyp-SDA-2026-04-04-frontier-proteomics-1c3dba72-2 (PPID/CypD mitochondrial proteostasis), hyp-SDA-2026-04-04-frontier-proteomics-1c3dba72-3 (SYN1 vesicle phosphorylation), hyp-SDA-2026-04-08-gap-debate-20260406-062033-16eccec1-1 (IL1R1/TNFRSF1A cytokine receptor), hyp-SDA-2026-04-08-gap-debate-20260406-062033-16eccec1-2 (SIRT1/PRKAA1/PPARGC1A circadian metabolic), hyp-SDA-2026-04-08-gap-debate-20260406-062033-16eccec1-3 (NR1D1/NR1D2 REV-ERB agonist), hyp-SDA-2026-04-08-gap-debate-20260406-062033-fecb8755-1 (NAMPT/CD38 NAD+ salvage), hyp-SDA-2026-04-08-gap-debate-20260406-062033-fecb8755-2 (MTOR TREM2-mTOR metabolic), hyp-SDA-2026-04-08-gap-debate-20260406-062033-fecb8755-3 (DGAT1 lipid droplets), hyp-SDA-2026-04-08-gap-debate-20260406-062033-fecb8755-5 (VDAC1-GRP75-IP3R1 MAM), hyp-SDA-2026-04-08-gap-debate-20260406-062045-ce866189-1 (NLRP3 compensatory cytokine), hyp-SDA-2026-04-08-gap-debate-20260406-062045-ce866189-7 (AQP4 glymphatic), hyp-SDA-2026-04-08-gap-pubmed-20260406-062111-db808ee9-1 (C5AR1 complement spinal cord), hyp-SDA-2026-04-08-gap-pubmed-20260406-062111-db808ee9-3 (VEGFA spinal vascular), hyp-SDA-2026-04-08-gap-pubmed-20260406-062111-db808ee9-4 (STAT3 astrocyte reactivity).post_validate_failures [].